Mablon Biotech Private Limited
About Mablon Biotech Private Limited
Data last updated:
Mablon Biotech Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 04 October 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2013PTC248873. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ashish Ashokkumar Dubey and Vijayan Rajaram Barnam.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Pitch No 85/N/Sg/1. Near Ambedkar Statue E Highway Road Ramabai Ambedkar Nagar, Mumbai, Maharashtra, India – 400075.
As per the financials filed for FY 2019, the company reported a revenue of ₹58,945, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹8,671 (net margin -14.7%) and EBITDA of ₹15,366 (EBITDA margin 26.1%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mablon Biotech Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPitch No 85/N/Sg/1. Near Ambedkar Statue E Highway Road Ramabai Ambedkar Nagar, Mumbai, Maharashtra, India – 400075
- IndustryLife Sciences, Biotechnology
To see the full contact details of Mablon Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mablon Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mablon Biotech Private Limited, buy the company report.
Financials of Mablon Biotech Private Limited
FY 2019 filings availableMablon Biotech Private Limited reported revenue of ₹58,945 (up 244% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 31% over three years, including 244% growth in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹58,945 | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15,366 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8,671 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.1% | ||||
| Net Profit Margin | -14.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mablon Biotech Private Limited, buy the company report.
Board of directors of Mablon Biotech Private Limited
Mablon Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Ashokkumar Dubey | Director | 04 Oct 2013 | 13 Years 0 Months | Current |
| Vijayan Rajaram Barnam | Director | 05 Nov 2016 | 9 Years 11 Months | Current |
Auditor
Mablon Biotech Private Limited is audited by GOUSH ABDULLA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOUSH ABDULLA & CO | FY 2019 | 138068W |
Shareholding
The shareholding of Mablon Biotech Private Limited is on record for 5 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mablon Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mablon Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mablon Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mablon Biotech has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Mablon Biotech Private Limited, buy the company report.
Recent activity
Mablon Biotech Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Arvindkumar Dubey ceased to be Director on 10 Nov 2016.
Frequently asked questions
Mablon Biotech is an active private limited company based in Mumbai, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 04 October 2013 (13+ years old) and is registered under CIN U74120MH2013PTC248873.
Mablon Biotech has 2 current directors:
- Ashish Ashokkumar Dubey - Director
- Vijayan Rajaram Barnam - Director
The latest financial statements of Mablon Biotech on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Mablon Biotech has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Mablon Biotech is U74120MH2013PTC248873. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mablon Biotech was incorporated on 04 October 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Arvindkumar Dubey ceased to be Director on 10 Nov 2016. Vijayan Rajaram Barnam was appointed as Director on 05 Nov 2016. Ashish Ashokkumar Dubey was appointed as Director on 04 Oct 2013.
The registered office of Mablon Biotech is at Pitch No 85NSg1. Near Ambedkar Statue E Highway Road Ramabai Ambedkar Nagar, Mumbai, Maharashtra, India – 400075.
Mablon Biotech operates in the life sciences industry, in the biotechnology segment.
The compliance status of Mablon Biotech is compliant as of 13 August 2026. The company is actively filing with the Registrar of Companies.